Hafnium Complexes as Dose Enhancement Agents for Photon Capture Therapy and as Contrast Agents for Radiotherapy
- Авторлар: Lipengolts A.1,2,3, Skribitsky V.1,2, Finogenova Y.1,4, Shulyak A.3,4,5,6, Abakumov M.7, Bykov A.3, Grigorieva E.1, Smirnova A.1,8, Shpakova K.1,2, Zhizhin K.3,5
-
Мекемелер:
- N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation
- National Research Nuclear University (Moscow Engineering Physics Institute)
- N.S. Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences
- Peoples' Friendship University of Russia named after Patrice Lumumba
- MIREA – Russian Technological University
- Leninsky prosp. 31, Moscow, 119991, Russia
- N.I. Pirogov Russian National Research Medical University
- Moscow Clinical Research Center named after A. S. Loginov, Moscow Healthcare Department
- Шығарылым: Том 69, № 1 (2024)
- Беттер: 173-182
- Бөлім: Complex systems biophysics
- URL: https://journals.rcsi.science/0006-3029/article/view/257135
- DOI: https://doi.org/10.31857/S0006302924010163
- EDN: https://elibrary.ru/QVANXR
- ID: 257135
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Авторлар туралы
A. Lipengolts
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation; National Research Nuclear University (Moscow Engineering Physics Institute); N.S. Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of SciencesKashirskoye Shosse 24, Moscow, 115478, Russia; Kashirskoe shosse 31, Moscow, 115409, Russia; Leninsky prosp. 31, Moscow, 119991, Russia
V. Skribitsky
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation; National Research Nuclear University (Moscow Engineering Physics Institute)Kashirskoye Shosse 24, Moscow, 115478, Russia; Kashirskoe shosse 31, Moscow, 115409, Russia
Yu. Finogenova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation; Peoples' Friendship University of Russia named after Patrice Lumumba
Email: b-f.finogenova@yandex.ru
Kashirskoye Shosse 24, Moscow, 115478, Russia; ul. Miklukho-Maklaya 6, Moscow, 117198, Russia
A. Shulyak
N.S. Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences; Peoples' Friendship University of Russia named after Patrice Lumumba; MIREA – Russian Technological University; Leninsky prosp. 31, Moscow, 119991, Russiaul. Miklukho-Maklaya 6, Moscow, 117198, Russia; prosp. Vernadskogo 78, Moscow, 119454, Russia
M. Abakumov
N.I. Pirogov Russian National Research Medical Universityul. Ostrovityanova 1, Moscow, 117997, Russia
A. Bykov
N.S. Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of SciencesLeninsky prosp. 31, Moscow, 119991, Russia
E. Grigorieva
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian FederationKashirskoye Shosse 24, Moscow, 115478, Russia
A. Smirnova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation; Moscow Clinical Research Center named after A. S. Loginov, Moscow Healthcare DepartmentKashirskoye Shosse 24, Moscow, 115478, Russia; Shosse Entuziastov 86, Moscow, 111123, Russia
K. Shpakova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation; National Research Nuclear University (Moscow Engineering Physics Institute)Kashirskoye Shosse 24, Moscow, 115478, Russia; Kashirskoe shosse 31, Moscow, 115409, Russia
K. Zhizhin
N.S. Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences; MIREA – Russian Technological UniversityLeninsky prosp. 31, Moscow, 119991, Russia; prosp. Vernadskogo 78, Moscow, 119454, Russia
Әдебиет тізімі
- Kulakov V. N., Lipengol'ts A. A., Grigor'eva E. Y., andShimanovskii N. L. Pharmaceuticals for binary radiotherapy and their use for treatment of malignancies. Pharm. Chem. J., 50 (6), 388–393 (2016). doi: 10.1007/s11094-016-1457-3
- Kulakov V. N., Lipengol’ts A. A., and Shimanovskii N. L., Pharmaceuticals for binary radiotherapy. Russ. J. Gen. Chem., 83, 2559–2564 (2013). DOI: 10.1134/ S1070363213120542
- Sheino I. N., Izhevskij P. V., Lipengolts A. A.,Kulakov V. N., Wagner A. A., Sukhikh E. S., and Varlachev V. F. Development of binary technologies of radiotherapy of malignant neoplasms: condition and problems. Bull. Siber. Med., 16 (3), 192–209 (2017). doi: 10.20538/1682-0363-2017-3-192-209
- Липенгольц А. А., Арнопольская А. М., Шейно И. Н.и Кулаков В. Н. Экспериментальное подтверждение противоопухолевой эффективности нейтронзахватной терапии с гадолинием. Онкологический журн., 3 (2), 63–70 (2020). doi: 10.37174/2587-75932020-3-2-63-70
- Rose J. H., Norman A., Ingram M., Aoki C., SolbergT., and Mesa A. First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx). Int. J. Radiat. Oncol. Biol. Phys., 45 (5), 1127–1132 (1999). doi: 10.1016/S0360-3016(99)00347-8
- Adam J.-F., Vautrin M., Obeid L., Tessier A., Prezado Y., Renier M., Nemoz Ch., Brochard Th., Bravin A., Bas J., Elleaume H., Berkvens P., Balosso J., and Estève F. Contrast-enhanced Synchrotron Stereotactic Radiotherapy Clinical Trials from a Medical Physicist Point of View. Int. J. Radiat. Oncol. Biol. Phys., 90, S16–S17 (2014). doi: 10.1016/j.ijrobp. 2014.05.103.
- Lux F., Tran V. L., Thomas E., Dufort S., Rossetti F.,Martini M., Truillet C., Doussineau T., Bort G., Denat F., Boschetti F., Angelovski G., Detappe A., Crémillieux Y., Mignet N., Doan B. T., Larrat B., Meriaux S., Barbier E., Roux S., Fries P., Müller A., Abadjian M. C., Anderson C., Canet-Soulas E., Bouziotis P., Barberi-Heyob M., Frochot C., Verry C., Balosso J., Evans M., Sidi-Boumedine J., Janier M., Butterworth K., McMahon S., Prise K., Aloy M. T., Ardail D., Rodriguez-Lafrasse C., Porcel E., Lacombe S., Berbeco R., Allouch A., Perfettini J. L., Chargari C., Deutsch E., Le Duc G., and Tillement O. AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine. Br. J. Radiol., 92 (1093), 20180365 (2019). doi: 10.1259/bjr.20180365
- Hainfeld J. F., Ridwan S. M., Stanishevskiy Y.,Panchal R., Slatkin D. N., and Smilowitz H. M. Iodine nanoparticles enhance radiotherapy of intracerebral human glioma in mice and increase efficacy of chemotherapy. Sci. Rep., 9, 4505 (2019).
- Hainfeld J. F., Smilowitz H. M., O'Connor M. J., Dilmanian F. A., and Slatkin D. N. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine (Lond.), 8 (10), 1601–1609 (2013). doi: 10.2217/nnm.12.165
- Norman A., Ingram M., Skillen R. G., Freshwater D.B., Iwamoto K. S., and Solberg T. X-ray phototherapy for canine brain masses. Radiat. Oncol. Investig., 5 (1), 8–14 (1997). doi: 10.1002/(SICI)1520-6823(1997)5:1<8::AID-ROI2>3.0.CO;2-1
- X-Ray Mass Attenuation Coefficients: NIST Standard Reference Database 126. URL: https://www.nist.gov/ pml/x-ray-mass-attenuation-coefficients (Дата обращения 17.07.2023).
- Bonvalot S., Rutkowski P. L., Thariat J., Carrère S.,Ducassou A., Sunyach M. P., Agoston P., Hong A., Mervoyer A., Rastrelli M., Moreno V., Li R. K., Tiangco B., Herraez A. C., Gronchi A., Mangel L., SyOrtinT., Hohenberger P., de Baère T., Le Cesne A., Helfre S., Saada-Bouzid E., Borkowska A., Anghel R., Co A., Gebhart M., Kantor G., Montero A., Loong H. H., Vergés R., Lapeire L., Dema S., Kacso G., Austen L., Moureau-Zabotto L., Servois V., Wardelmann E., Terrier P., Lazar A. J., Bovée J. V. M. G., Le Péchoux C., and Papai Z. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. Lancet Oncol. 20 (8), 1148–1159 (2019). doi: 10.1016/S14702045(19)30326-2
- Shulyak A. T., Bortnikov E. O., Kubasov A. S., Selivanov N. A., Lipengolts A. A., Zhdanov A. P., Bykov A. Y., Zhizhin K. Y., and Kuznetsov N. T. Synthesis of Hafnium(IV) Polyaminoacetates. Molecules (Basel, Switzerland), 26 (12), Art. 3725 (2021). doi: 10.3390/molecules26123725
- Lipengolts A. A., Cherepanov A. A., Kulakov V. N.,Grigorieva E. Y., Sheino I. N., and Klimanov V. A. Antitumor efficacy of extracellular complexes with gadolinium in Binary Radiotherapy. Appl. Radiat. Isot., 106, 233–236 (2015). doi: 10.1016/j.apradiso.2015.07.051
- Lipengolts A. A., Budaeva J. A., Blaickner M., Cherepanov A. A., Menkov M. A., Kulakov V. N., and Grigorieva, E. Iodine quantification with computed tomography for the purpose of dose assessment in contrast enhanced radiotherapy. Bull. Russ. State Med. Univ., (6), 16–19 (2016). doi: 10.24075/brsmu.2016-06-03
- Lipengol’ts A. A., Cherepanov A. A., Kulakov V. N.,Grigor’eva E. Y., Merkulova I. B., and Sheino I. N. Comparison of the antitumor efficacy of bismuth and gadolinium as dose-enhancing agents in formulations for photon capture therapy. Pharm. Chem., 51, 783– 786 (2017). doi: 10.1007/s11094-017-1693-1
- Hoffmann C., Calugaru V., Borcoman E., Moreno V.,Calvo E., Liem X., Salas S., Doger B., Jouffroy Th., Mirabel X., Rodriguez J., Chilles A., Bernois K., Dimitriu M., Fakhry N., and Wong Hee Kam S. Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx. Eur. J. Cancer, 146, 135–144 (2021). doi: 10.1016/j.ejca.2021.01.007
- Bonvalot S., Rutkowski P. L., Thariat J., Carrère S.,Ducassou A., Sunyach M. P., Agoston P., Hong A. M., Mervoyer A., Rastrelli M., Moreno V., Li R. K., Tiangco B. J., Herráez A. C., Gronchi A., Sy-Ortin T., Hohenberger P., de Baère T., Cesne A. L., Helfre S., Saada-Bouzid E., Anghel R. M., Kantor G., Montero A., Loong H. H, Vergés R., Kacso G., Austen L., Servois V. F., Wardelmann E., Dimitriu M., Said P., Lazar A. J., Bovée J. V. M. G., Péchoux C. L., and Pápai Z. Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma. Int. J. Radiat. Oncol. Biol. Phys. 114 (3), 422– 432 (2022). doi: 10.1016/j.ijrobp.2022.07.001
- Lipengolts A. A., Vorobyeva E. S., Cherepanov A. A.,Abakumov M. A., Abakumova T. O., Smirnova A. V., Finogenova Yu. A., Grigorieva E. Yu., Sheino I. N., and Kulakov V. N. Bull. Russ. State Med. Univ., 5, 60– 64 (2018). doi: 10.24075/brsmu.2018.062